Comparison of two vasoconstrictors on glycemic levels in diabetic patients.
Daniela Meneses-SantosKlinger Souza AmorimAnne Caroline Gercina Carvalho DantasRicardo Pedro da SilvaJaiza Samara Macena de AraújoFrancisco Carlos GroppoLiane Maciel Almeida SouzaPublished in: Clinical oral investigations (2020)
Thus, both lido/epi and prilo/fely (maximum 3.6 mL) can be safely used in controlled diabetic patients CLINICAL RELEVANCE: The use of lidocaine associated with epinephrine did not increase glycemic levels but leads to decrease over time when associated with an anxiety reduction protocol, offering some advantage over prilocaine plus felypressin for diabetic patients.